Valuation AstraZeneca PLC Boerse Muenchen

Stocks

Real-time Boerse Muenchen			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-1.26%

02:00pm	AstraZeneca PLC : Gets a Sell rating from Deutsche Bank	ZD
10:11am	AstraZeneca PLC : Berenberg reiterates its Buy rating	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	244,757	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-14.96%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	264,207	256,523	248,009
Change	-	12.57%	-0.25%	-1.74%	36.64%	-15.1%	-2.91%	-3.32%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	20.3x	17.7x	15.3x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.55x	4.06x	3.45x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.2x	1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	3.87x	3.66x	3.43x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.17x	3.83x	3.48x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	11.9x	10.6x	9.26x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	12.5x	11x	9.7x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	28x	19.6x	16.9x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.57%	5.09%	5.93%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.339	3.561	3.66
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	2.12%	2.26%	2.32%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.782	8.932	10.32
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	42.9%	39.9%	35.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,300	66,898	71,335
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,158	24,298	26,772
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,072	23,269	25,560
Net income ¹	112	3,288	5,961	7,035	10,225	12,026	13,767	15,794
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,450	11,766	3,252
Reference price ²	117.51	135.16	135.02	131.05	185.60	157.80	157.80	157.80
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22 A	2/9/23 A	2/8/24 A	2/6/25 A	2/10/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32x	11.63x	23.59x	0.62%	1,002B
JOHNSON & JOHNSON	28.37x	6.53x	17.91x	2.01%	644B
ABBVIE INC.	32.13x	7.46x	15.49x	2.73%	443B
ROCHE HOLDING AG	18.9x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	19.46x	5.11x	12.69x	3.2%	262B
ASTRAZENECA PLC	20.29x	4.17x	11.93x	2.12%	245B
AMGEN INC.	24.75x	6.5x	11.57x	2.58%	212B
NOVO NORDISK A/S	12.86x	4.67x	9.75x	3.91%	199B
GILEAD SCIENCES, INC.	-44.5x	6.43x	25.11x	2.26%	181B
Average	16.03x	6.35x	15.50x	2.48%	392.19B
Weighted average by Cap.	22.91x	7.53x	17.31x	2.04%